• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

2 Cannabinoid Biotech Companies Presenting at the RBC Conference

February 20, 2018

 

With two different cannabinoid-related biotech companies set to present this week at the 2018 RBC Capital Markets Global Healthcare Conference including Insys Therapeutics, Inc. (NASDAQ:INSY) and more, we wanted to give you a head-start on which stocks to keep an eye on for later in the week.

 

The conference is set to take place Wednesday, February 21st through Thursday, February 22nd in New York City, with numerous companies expected to present.

 

It's important to pay attention whenever one of your current or prospective portfolio holdings is participating in major conferences. First and foremost, the increased awareness garnered by these conferences can move stock prices. Secondly, the companies participating usually have one of their top executives giving an overview of their company and what's to come.

 

Here's two cannabinoid-related pharma stocks expected to present this week, in alphabetical order:

 

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP)

 

Corbus CEO Yuval Cohen, Ph.D. will be presenting in a fireside chat at the 2018 RBC Capital Markets Global Healthcare Conference on Thursday, February 22nd at 3:35 p.m. EST. Dr. Cohen will discuss the company's four clinical development programs in diffuse cutaneous systemic sclerosis, cystic fibrosis, skin-predominant dermatomyositis and systemic lupus erythematosus for lenabasum, its novel, synthetic oral endocannabinoid-mimetic drug that is designed to resolve chronic inflammation and halt fibrosis.

 

Insys Therapeutics, Inc. (NASDAQ:INSY)

 

Insys CEO Saeed Motahari and CFO Andrew Long will be presenting at the 2018 RBC Capital Markets Global Healthcare Conference on Thursday, February 22nd at 10:00 a.m. EST at the Lotte New York Palace Hotel. In addition to making a presentation, management will also provide an overview of the company’s business in one-on-one meetings with investors who are registered to attend the conference.

 

Be sure to subscribe to one or more of our free e-mail newsletters so you never miss an important marijuana stock update. Also, don't forget to connect with The Daily Marijuana Observer on social media via FacebookTwitterStockTwits, and Instagram.

 

D/M/O

Please reload

LATEST NEWS
Please reload

Please reload

DMO

© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.